The total number of BA.4 and BA.5 cases detected in Indonesia has reached 143 within the past week, a steep increase from 20 cases recorded as of June 14, 2022, the ministry’s spokesperson, Mohammad Syaril, said in a virtual press statement released on YouTube.
Currently, the number of BA.4 and BA.5 cases has reached 21 and 122, respectively. In addition to Jakarta, BA.4 and BA.5 cases have also been detected in West Java (29 cases), Banten (13 cases), and Bali (3 cases), he elaborated.
Of the patients infected with the Omicron subvariants, 34 have received the booster shot, nine have been completely vaccinated against COVID-19, three have received only the first dose, and one has received four doses of the coronavirus vaccine.
"The five other were experienced by children who had not received the COVID-19 vaccine, while for the rest of the 90 patients, there has not been any data update," Syahril said.
Based on gender, 73 patients are male while 70 are female, he informed.
In addition, 38 patients have reported experiencing symptoms, while nine patients have not presented with any symptoms. Data on the remaining 96 patients is yet to be updated.
Based on age, the highest number of patients are from the productive age group of 30–39 years at 34.
Meanwhile, 29 patients are aged between 20–29 years, while 20 patients are elderly.
The most dominant symptoms experienced by BA.5 patients are cough (30 percent), fever (25 percent), cold (19 percent), and sore throat (14 percent).
The other symptoms include nausea, shortness of breath, and anosmia.
Among BA.4 patients, the most dominant symptoms are cough (38 percent), fever (29 percent), sore throat (24 percent), and cold (9 percent).
Related news: Jakarta urged to prevent COVID spike as subvariants emerge
Related news: Jakarta gov't urges public to immediately complete booster vaccination
Related news: 21 provinces record increase in COVID-19 cases: ministry
Translator: Andi Firdaus, Fadhli Ruhman
Editor: Sri Haryati
Copyright © ANTARA 2022
